William Quinn
Director of Finance/CFO at BOLT BIOTHERAPEUTICS, INC.
Net worth: 50 781 $ as of 31/03/2024
William Quinn active positions
| Companies | Position | Start | End |
|---|---|---|---|
| BOLT BIOTHERAPEUTICS, INC. | Director of Finance/CFO | 01/05/2020 | - |
Neurogastrx, Inc.
 Neurogastrx, Inc. BiotechnologyHealth Technology Neurogastrx, Inc. operates as a venture-stage biopharmaceutical company. The firm develops biopharmaceutical products for the treatment of gastrointestinal disorders. It offers NG101, a product for the treatment of gastroparesis. The company was founded by Cyril De Colle and Pankaj Jay Pasricha and is headquartered in Campbell, CA. | Director/Board Member | - | - |
| Solar Roof Dynamics LLC | Director/Board Member | 01/11/2017 | - |
| A Foundation Building Strength For Nemaline Myopathy | Director/Board Member | 01/03/2011 | - |
Career history of William Quinn
Former positions of William Quinn
| Companies | Position | Start | End |
|---|---|---|---|
| VIRACTA THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 30/11/2017 | 01/05/2020 |
| Director of Finance/CFO | 30/11/2017 | 01/05/2020 | |
| Investor Relations Contact | - | 01/05/2020 | |
Midnight Pharmaceuticals, Inc.
 Midnight Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Midnight Pharmaceuticals, Inc. develops novel products for the treatment of insomnia. The CEO of the American company is Jed Black. | Director/Board Member | 01/03/2013 | 01/02/2019 |
Bullet Biotechnology, Inc.
 Bullet Biotechnology, Inc. BiotechnologyHealth Technology Bullet Biotechnology, Inc. develops active immunotherapies to stimulate a person’s own immune system to overcome diseases. Its technology educates the immune system to targeting specific cells that are causing disease. The firm's pipeline includes therapeutic vaccines for cancer, multi-specific antibody capsid products, therapeutic vaccines for autoimmune diseases, and other vaccines. The company was founded by Diego Fonstad, James R. Swartz, Willie Quinn and Thomas Theriault in September 2011 and is headquartered in Redwood City, CA. | Director/Board Member | 01/09/2011 | 01/11/2017 |
| Chief Executive Officer | 01/09/2011 | 01/11/2017 | |
| Founder | 01/09/2011 | 01/11/2017 | |
| President | 01/09/2011 | 01/11/2017 | |
Jazz Pharmaceuticals, Inc.
 Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its medical products include xyrem, erwinaze, vyxeos, and kidrolas. The company was founded by Bruce C. Cozadd in 2003 and is headquartered in Palo Alto, CA. | Corporate Officer/Principal | 01/03/2003 | 01/06/2011 |
| Novation Biosciences, Inc. | Chief Operating Officer | 01/09/2001 | 01/12/2002 |
| Director of Finance/CFO | 01/09/2001 | 01/12/2002 |
Training of William Quinn
| Stanford University | Graduate Degree |
| Stanford Graduate School of Business | Masters Business Admin |
Statistics
International
| United States | 12 |
Operational
| Director/Board Member | 5 |
| Director of Finance/CFO | 3 |
| Corporate Officer/Principal | 1 |
Sectoral
| Health Technology | 7 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| BOLT BIOTHERAPEUTICS, INC. | Health Technology |
| Private companies | 8 |
|---|---|
Jazz Pharmaceuticals, Inc.
Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its medical products include xyrem, erwinaze, vyxeos, and kidrolas. The company was founded by Bruce C. Cozadd in 2003 and is headquartered in Palo Alto, CA. | Health Technology |
Sunesis Pharmaceuticals, Inc.
 Sunesis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sunesis Pharmaceuticals, Inc. engages in the development and commercialization of new oncology therapeutics for the treatment of solid and hematologic cancers. The firm's activities include conducting research and development internally and through corporate collaborators, in-licensing and out-licensing pharmaceutical compounds and technology, conducting clinical trials and raising capital. The company was founded on February 10, 1998 and is headquartered in South San Francisco, CA. | Health Technology |
Bullet Biotechnology, Inc.
Bullet Biotechnology, Inc. BiotechnologyHealth Technology Bullet Biotechnology, Inc. develops active immunotherapies to stimulate a person’s own immune system to overcome diseases. Its technology educates the immune system to targeting specific cells that are causing disease. The firm's pipeline includes therapeutic vaccines for cancer, multi-specific antibody capsid products, therapeutic vaccines for autoimmune diseases, and other vaccines. The company was founded by Diego Fonstad, James R. Swartz, Willie Quinn and Thomas Theriault in September 2011 and is headquartered in Redwood City, CA. | Health Technology |
| Novation Biosciences, Inc. | |
Neurogastrx, Inc.
Neurogastrx, Inc. BiotechnologyHealth Technology Neurogastrx, Inc. operates as a venture-stage biopharmaceutical company. The firm develops biopharmaceutical products for the treatment of gastrointestinal disorders. It offers NG101, a product for the treatment of gastroparesis. The company was founded by Cyril De Colle and Pankaj Jay Pasricha and is headquartered in Campbell, CA. | Health Technology |
| Solar Roof Dynamics LLC | |
Midnight Pharmaceuticals, Inc.
Midnight Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Midnight Pharmaceuticals, Inc. develops novel products for the treatment of insomnia. The CEO of the American company is Jed Black. | Health Technology |
| A Foundation Building Strength For Nemaline Myopathy |
- Stock Market
- Insiders
- William Quinn
- Experience